Sensorion to Participate in the Jefferies London Healthcare Conference and McDermott Will & Emery's Life Sciences Symposium
Regulatory News: Sensorion (FR0012596468 – ALSEN) (PARIS:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field
Source: benzinga.com